An initiative of this type will benefit from coordinated efforts as have never been seen before, since expertise is required in many subdisciplines spanning biology, chemistry and physics ...

Jhoti started as Chief Scientific Officer, leading the development of the ... focusing on structure-based drug design. There, as Vice President of Structural Biology, he played a substantial ...

COMSTECH, the Ministerial Standing Committee on Scientific and Technological Cooperation of the OIC, in collaboration with ...

Despite a crowded GLP-1 drug development field ... Dr. Stevens conducted postdoctoral research in structural biology at Harvard University with William Lipscomb, who was awarded the Nobel Prize ...

Nuclera, the biotechnology company accelerating protein expression and optimization through its benchtop eProtein Discovery™ system, today announced the addition of a new membrane protein workflow to ...

Oncodesign Services has appointed Dr. Aidan Synnott as chief executive officer, to help strengthen its position as a trusted partner in drug discovery. The appointment reflects the company’s ...

The "Drug Discovery Services Market by Process (Target Validation, Hit-to-Lead, Lead Optimization), Type (Chemistry, Biology), Therapeutic Area (Oncology, Neurology, Infectious, CVD), Drug Type (Small ...

The cluster features a vibrant group of more than two dozen accomplished and highly collaborative faculty with diverse research interests in structural biology, drug design, mechanistic biology, ...